ArticleJournal for immunotherapy of cancer2020

Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2.

Michael Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.